Measurement of brain iron distribution in hallevorden-spatz syndrome

Jerzy Szumowski, Erhan Bas, Kirsten Gaarder, Erwin Schwarz, Deniz Erdogmus, Susan Hayflick

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: To investigate spatial distribution of iron accumulation in the globus pallidus (GP) in patients with Hallevorden-Spatz syndrome (HSS) using phase imaging. We compared sensitivity of a phase imaging technique to relaxation rate measurement methods (R1,R2,R2*) for iron quantification. Materials and Methods: R1, R2, and R2* were measured in GP structure of the brain of eight pantothenate kinase-associated neurodegeneration (PKAN) patients and a healthy volunteer using a 3T magnetic resonance imaging (MRI) scanner. The phase of gradient-echo images was preprocessed to eliminate phase 2p wrapping and filtered to remove phase background variations. Phase gap across GP structure was used as a metric for iron effects quantification. Results: Among the relaxation rates the most sensitive to iron accumulation was the R2* rate. The R1 and R2 rates demonstrated only small variations in this group of subjects. Up to an order of magnitude phase gap changes were measured between one PKAN patient and an age-matched healthy volunteer. Assuming that phase gap differences scale linearly with iron concentration we estimate that up to 2 mg Fe/g ww accumulates in GP of these patients. Conclusion: Our results demonstrate significantly higher sensitivity of the phase measurements for quantitative assessment of iron concentration compared to the relaxation rate measurements. Phase measurements could potentially be used for monitoring a progression and a response to therapy in PKAN.

Original languageEnglish (US)
Pages (from-to)482-489
Number of pages8
JournalJournal of Magnetic Resonance Imaging
Volume31
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Globus Pallidus
Pantothenate Kinase-Associated Neurodegeneration
Iron
Brain
Healthy Volunteers
Relaxation Therapy
Magnetic Resonance Imaging
Therapeutics

Keywords

  • Hallevorden-spatz syndrome
  • Iron
  • MRI
  • Pantothenate kinase-associated neurodegeneration (PKAN)
  • Phase imaging
  • Susceptibility SWI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Measurement of brain iron distribution in hallevorden-spatz syndrome. / Szumowski, Jerzy; Bas, Erhan; Gaarder, Kirsten; Schwarz, Erwin; Erdogmus, Deniz; Hayflick, Susan.

In: Journal of Magnetic Resonance Imaging, Vol. 31, No. 2, 02.2010, p. 482-489.

Research output: Contribution to journalArticle

Szumowski, Jerzy ; Bas, Erhan ; Gaarder, Kirsten ; Schwarz, Erwin ; Erdogmus, Deniz ; Hayflick, Susan. / Measurement of brain iron distribution in hallevorden-spatz syndrome. In: Journal of Magnetic Resonance Imaging. 2010 ; Vol. 31, No. 2. pp. 482-489.
@article{dd3a4863a4ba4e6081a47ba797693baf,
title = "Measurement of brain iron distribution in hallevorden-spatz syndrome",
abstract = "Purpose: To investigate spatial distribution of iron accumulation in the globus pallidus (GP) in patients with Hallevorden-Spatz syndrome (HSS) using phase imaging. We compared sensitivity of a phase imaging technique to relaxation rate measurement methods (R1,R2,R2*) for iron quantification. Materials and Methods: R1, R2, and R2* were measured in GP structure of the brain of eight pantothenate kinase-associated neurodegeneration (PKAN) patients and a healthy volunteer using a 3T magnetic resonance imaging (MRI) scanner. The phase of gradient-echo images was preprocessed to eliminate phase 2p wrapping and filtered to remove phase background variations. Phase gap across GP structure was used as a metric for iron effects quantification. Results: Among the relaxation rates the most sensitive to iron accumulation was the R2* rate. The R1 and R2 rates demonstrated only small variations in this group of subjects. Up to an order of magnitude phase gap changes were measured between one PKAN patient and an age-matched healthy volunteer. Assuming that phase gap differences scale linearly with iron concentration we estimate that up to 2 mg Fe/g ww accumulates in GP of these patients. Conclusion: Our results demonstrate significantly higher sensitivity of the phase measurements for quantitative assessment of iron concentration compared to the relaxation rate measurements. Phase measurements could potentially be used for monitoring a progression and a response to therapy in PKAN.",
keywords = "Hallevorden-spatz syndrome, Iron, MRI, Pantothenate kinase-associated neurodegeneration (PKAN), Phase imaging, Susceptibility SWI",
author = "Jerzy Szumowski and Erhan Bas and Kirsten Gaarder and Erwin Schwarz and Deniz Erdogmus and Susan Hayflick",
year = "2010",
month = "2",
doi = "10.1002/jmri.22031",
language = "English (US)",
volume = "31",
pages = "482--489",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Measurement of brain iron distribution in hallevorden-spatz syndrome

AU - Szumowski, Jerzy

AU - Bas, Erhan

AU - Gaarder, Kirsten

AU - Schwarz, Erwin

AU - Erdogmus, Deniz

AU - Hayflick, Susan

PY - 2010/2

Y1 - 2010/2

N2 - Purpose: To investigate spatial distribution of iron accumulation in the globus pallidus (GP) in patients with Hallevorden-Spatz syndrome (HSS) using phase imaging. We compared sensitivity of a phase imaging technique to relaxation rate measurement methods (R1,R2,R2*) for iron quantification. Materials and Methods: R1, R2, and R2* were measured in GP structure of the brain of eight pantothenate kinase-associated neurodegeneration (PKAN) patients and a healthy volunteer using a 3T magnetic resonance imaging (MRI) scanner. The phase of gradient-echo images was preprocessed to eliminate phase 2p wrapping and filtered to remove phase background variations. Phase gap across GP structure was used as a metric for iron effects quantification. Results: Among the relaxation rates the most sensitive to iron accumulation was the R2* rate. The R1 and R2 rates demonstrated only small variations in this group of subjects. Up to an order of magnitude phase gap changes were measured between one PKAN patient and an age-matched healthy volunteer. Assuming that phase gap differences scale linearly with iron concentration we estimate that up to 2 mg Fe/g ww accumulates in GP of these patients. Conclusion: Our results demonstrate significantly higher sensitivity of the phase measurements for quantitative assessment of iron concentration compared to the relaxation rate measurements. Phase measurements could potentially be used for monitoring a progression and a response to therapy in PKAN.

AB - Purpose: To investigate spatial distribution of iron accumulation in the globus pallidus (GP) in patients with Hallevorden-Spatz syndrome (HSS) using phase imaging. We compared sensitivity of a phase imaging technique to relaxation rate measurement methods (R1,R2,R2*) for iron quantification. Materials and Methods: R1, R2, and R2* were measured in GP structure of the brain of eight pantothenate kinase-associated neurodegeneration (PKAN) patients and a healthy volunteer using a 3T magnetic resonance imaging (MRI) scanner. The phase of gradient-echo images was preprocessed to eliminate phase 2p wrapping and filtered to remove phase background variations. Phase gap across GP structure was used as a metric for iron effects quantification. Results: Among the relaxation rates the most sensitive to iron accumulation was the R2* rate. The R1 and R2 rates demonstrated only small variations in this group of subjects. Up to an order of magnitude phase gap changes were measured between one PKAN patient and an age-matched healthy volunteer. Assuming that phase gap differences scale linearly with iron concentration we estimate that up to 2 mg Fe/g ww accumulates in GP of these patients. Conclusion: Our results demonstrate significantly higher sensitivity of the phase measurements for quantitative assessment of iron concentration compared to the relaxation rate measurements. Phase measurements could potentially be used for monitoring a progression and a response to therapy in PKAN.

KW - Hallevorden-spatz syndrome

KW - Iron

KW - MRI

KW - Pantothenate kinase-associated neurodegeneration (PKAN)

KW - Phase imaging

KW - Susceptibility SWI

UR - http://www.scopus.com/inward/record.url?scp=75749115164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749115164&partnerID=8YFLogxK

U2 - 10.1002/jmri.22031

DO - 10.1002/jmri.22031

M3 - Article

VL - 31

SP - 482

EP - 489

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 2

ER -